|1||Active, not recruiting||
Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma
|2||Active, not recruiting||
Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
|3||Not yet recruiting||
Pembrolizumab in Refractory Advanced Esophageal Cancer
Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder
† Study has passed its completion date and status has not been verified in more than two years.